(Q48276539)

10 February 2018

title

Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors (English)

1 reference

10 February 2018

1 reference

1 reference

Burkhard Emanuel Jabs

series ordinal

1

1 reference

10 February 2018

Andreas Joachim Bartsch

series ordinal

2

1 reference

10 February 2018

Bruno Pfuhlmann

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

10 February 2018

published in

European Psychiatry

1 reference

10 February 2018

volume

18

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

177-181

1 reference

10 February 2018

Central actions of nicotine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

A combined analysis of double-blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Effect of smoking on neuroleptics in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

[Tobacco use and smoking cessation in the psychiatric patient]

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Smoking, smoking cessation, and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Neuroleptic-induced parkinsonism in older schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Cigarette smoking: effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

Cigarette smoking and neuroleptic-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2803%2900045-2

7 January 2021

10.1016/S0924-9338(03)00045-2

Identifiers

DOI

1 reference

10 February 2018

release_lk5cijiybra2fdr4ob6upnjtgi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lk5cijiybra2fdr4ob6upnjtgi

24 November 2022

mapped directly with Wikidata item

1 reference

10 February 2018